CCL2 and glioblastoma: In summary, this study shows that the suppression of CCL2 can play an important role in increasing the anti-angiogenic treatment efficacy in GBM by inhibiting the recruitment of CCL2-dependent macrophages in a rodent model, which was successfully monitored with DSC perfusion MRI.